Burim N. Ametaj

Systems biology maps extensive networks but lacks a general principle identifying the minimum functional architecture of living organization. The Triadic Principle of Biology (TPB) proposes that stable, self-regulating biological systems require coordinated closure among three functionally distinguishable domains: Information, Energy/Material Transformation, and Interface/Boundary. These are categories of biological work rather than anatomical structures. This article states the claim, gives explicit rules for assigning a process to a domain and for fixing the system boundary, defines autonomy independently of the framework, and evaluates candidate manifestations in genetic coding, translation, cellular organization, epigenetics, development, physiology, evolution and disease against prospective admissibility criteria. The codon inequality provides one exact result, but it concerns code word length rather than functional domains and is not evidence for the TPB. The framework contributes a standardized functional vocabulary, criteria distinguishing genuine triads from arbitrary groupings, a taxonomy of failure modes, an operationalized closure index with explicit scoring functions and a worked example, and falsifiable predictions, including specified comparisons against rival decompositions such as sensing–regulation–action, supply–demand–control and Wicken’s exploitation–homeostasis dyad. Gánti’s chemoton is identified as the closest formal antecedent. Because these predictions remain untested, the article specifies the experiments and outcomes that would support, weaken or reject the principle.

Six conditions of the peripartum dairy cow—ketosis, lameness, milk fever, metritis, retained placenta, and subclinical mastitis—are conventionally studied as independent diseases. Here, an integrative re-analysis of metabolomic data from one cohort studied in the author’s laboratory (University of Alberta, Edmonton, Canada), most of them previously published, spanning three biofluids (serum, urine, and milk) and four analytical platforms (DI-LC-MS/MS, GC-MS, ¹H-NMR, and ICP-MS) evaluates the hypothesis that they are alternative clinical presentations of a single metabolic-immune syndrome whose proposed proximal trigger during the dry-off period is endotoxin (LPS) translocation from the involuting mammary gland, with three concurrent postpartum contributors: continuing mammary involvement and new intramammary infection; gastrointestinal LPS translocation under concentrate-rich feeding; and uterine LPS and Gram-positive lipoteichoic acid absorbed across the involuting endometrium. Four predictions were evaluated. (i) Cross-disease similarity of metabolic effect-size vectors is positive in every matrix, on two complementary serum platforms, and at every timepoint examined (mean Spearman r = 0.35–0.81, lowest postpartum and at clinical diagnosis, where partial divergence is predicted). (ii) Thirteen serum metabolites are altered in the same direction in all six disease groups eight weeks before calving, with the kynurenine/tryptophan ratio elevated 2.8–4.0-fold and completely separating every disease group from controls (p = 8.7 × 10⁻⁶, the minimum attainable for the group sizes). (iii) The urinary metabolome strengthens through the dry-off period (peak concordance at −4 wk, 44 of 91 metabolites) and partially diverges at clinical disease. The disturbance did not appear to resolve with the clinical episode: at 8 weeks postpartum, the mean absolute deviation from contemporaneous controls was similar to that observed 8 weeks before calving (mean |log2 fold change| 0.71 vs. 0.73), and the six diseases still deviated in a shared direction. (iv) Milk shows a postpartum shift consistent with TLR4 signaling (lactate and TCA-cycle intermediates up; betaine down; cobalt up in all six diseases). Comorbidity, conventionally treated as a confounder, may instead be the expected phenotype of one syndrome with multiple vulnerable-organ exits. Because the evidence is correlational and LPS was not measured, the mammary origin remains a hypothesis; direct LPS quantification, source-resolved measurements, and evaluation of competing explanations (glucocorticoid-driven reprogramming, pre-existing nutritional differences, and gut-derived signals) are required. The framework yields falsifiable predictions for dry-off-targeted, syndrome-level prevention.

Physiology has long explained organismal stability through homeostasis, allostasis, feedback regulation, and related systems concepts. These frameworks remain essential, but each is most precise at a particular scale or mode of response. This manuscript proposes stratodynamics as a new theory of layered biological response in vertebrate physiology. The framework holds that biological response is organized through seven functional layers: molecular, subcellular, cellular, tissue, organ, systemic, and organismal. The layer names denote the compositional scale of the focal response unit rather than fixed anatomical compartments; layer assignment is functional and response-specific. Each layer reduces its own form of mismatch between actual and required state through a scale-appropriate architecture: molecular-state transition, intracellular integration, cellular-state transition, tissue program, organ output, systemic feedback, or organismal anticipation. The layers are coupled upward, downward, and laterally, allowing local events to become systemic responses and allowing organismal state to shape lower-layer readiness. Stratodynamics locates rather than replaces previous theories: homeostasis is preserved as the canonical systemic architecture, allostasis as organismal predictive regulation, and tissue repair, resolution biology, bioelectricity, and thermodynamic self-organization as complementary layer-specific contributors. The framework is presented as a theoretical synthesis and research program for veterinary and medical sciences.

Lameness is a major welfare and economic disorder in dairy production and a clinical sign with multiple causes. This review focuses on claw horn disruption lesions (CHDL), a major cause of periparturient lameness. Although hoof-centered prevention and treatment remain essential, preclinical systemic alterations, recurrence, and clustering with other transition-period disorders suggest that CHDL may sometimes represent the local expression of broader pathophysiology. We propose the Lameness Triad, in which three mechanisms converge: sustained endotoxemic pressure and TLR4-mediated innate immune activation, endothelial glycocalyx degradation and vascular dysfunction, and metabolic triage that reallocates resources from production toward defense. Their combined pathogenic pressure is proposed to produce clinical disease when it exceeds a cow-specific Susceptibility–Resilience Gate comprising mucosal barrier integrity, hepatic endotoxin clearance, immune calibration, redox reserve, hoof structural reserve, and prior damage. Ruminal dysbiosis, mammary involution, and postpartum uterine contamination may contribute to inflammatory and endotoxemic pressure, whereas the confined, continuously loaded digital corium may become a principal site of clinical expression. Longitudinal multi-omics studies identified inflammatory, urinary, and milk-metabolite alterations before diagnosis, with within-cohort serum and urine models discriminating cows that later became lame as early as eight weeks prepartum. These findings require prospective validation and do not establish the complete causal sequence. The framework extends, rather than replaces, established hoof-health programs and provides testable hypotheses for earlier detection, prevention, and selection for resilience.

Physiology has long explained organismal stability through homeostasis, allostasis, feedback regulation, and related systems concepts. These frameworks remain essential, but each is most precise at a particular scale or mode of response. This manuscript proposes stratodynamics as a layered theory of biological response in vertebrate physiology. The framework holds that biological response is organized through seven functional layers: molecular, subcellular, cellular, tissue, organ, systemic, and organismal. Each layer reduces its own form of mismatch between actual and required state through a scale-appropriate architecture: molecular-state transition, intracellular integration, cellular-state transition, tissue program, organ output, systemic feedback, or organismal anticipation. The layers are coupled upward, downward, and laterally, allowing local events to become systemic responses and allowing organismal state to shape lower-layer readiness. Stratodynamics therefore locates rather than replaces previous theories: homeostasis is preserved as the canonical systemic architecture, allostasis as organismal predictive regulation, and tissue repair, resolution biology, bioelectricity, and thermodynamic self-organization as complementary layer-specific contributors. The framework is presented as a theoretical synthesis and research program for veterinary and medical sciences.

Uterine infections (metritis and endometritis) are a leading cause of culling and reproductive failure in transition dairy cows, and antibiotic-resistant Gram-negative pathogens limit conventional therapy. This randomized, controlled, multi-farm field trial evaluated whether four intravaginal infusions of a host-adapted lactic acid bacteria (LAB) cocktail (Lactobacillus sakei FUA3089, Pediococcus acidilactici FUA3138, P. acidilactici FUA3140; 10⁸–10⁹ cfu/dose) at −3, −2, +3, and +4 weeks relative to calving reduce periparturient disease and improve milk production. A total of 526 pregnant cows (426 Holstein, 100 Jersey) from four commercial Alberta farms (automatic-milking, parlor, and certified-organic systems) were block-randomized within farm and parity to TRT1 (saline; n = 175), TRT2 (saline + skim milk; n = 176), or TRT3 (LAB cocktail in saline + skim milk; n = 175). Uterine infection incidence was assessed by Metricheck™ mucus scoring and transrectal ultrasonography at +3 and +4 weeks postpartum. Across the principal peripartum infectious outcomes, TRT3 showed a consistent protective effect: uterine infection incidence was lowest in TRT3 (18.8% vs. 25.1% in pooled controls; OR = 0.69; 95% CI, 0.44–1.09; an approximately 25% relative reduction; exact p = 0.12), and this metritis signal was additionally supported by a repeated-measures mixed model accounting for farm, parity, and week (p = 0.0175), although the Bonferroni-adjusted pairwise contrasts were tendencies (adjusted p ≈ 0.12), and the effect did not differ by parity (treatment × lactation interaction, p = 0.97). Subclinical mastitis was numerically lower in TRT3 than in pooled controls (5.3% vs. 8.9%; OR = 0.57; 95% CI, 0.27–1.24; exact p = 0.16), whereas retained placenta, milk fever, displaced abomasum, and lameness showed no clear cow-level treatment effect in the cow-level exact analyses. Milk yield increased significantly in multiparous cows, which produced 4.6 L/day more milk than TRT1 and 3.22 L/day more than TRT2 over the first 50 days in milk (p < 0.01 for both contrasts; treatment × parity interaction, p = 0.01). No effect was seen on milk composition, uterine involution, or reproductive performance. The trial supports intravaginal LAB as a candidate antibiotic-free prophylactic whose response depends on farm- and cow-level contexts and whose mechanisms require confirmation through microbiological and metabolic measurements.

Ketosis is one of the most economically significant metabolic disorders affecting periparturient dairy cows, causing production losses and predisposing animals to secondary complications. Current blood-based diagnostics are invasive and provide limited insight into the underlying metabolic perturbations. This study employed an integrated three-platform metabolomics approach to characterize milk metabolite alterations in ketotic Holstein dairy cows and to evaluate milk-based biomarker panels for early ketosis detection. Milk samples from 20 healthy control (CON) cows and 6 ketotic cows were collected at 2 weeks postpartum and analyzed by direct injection/liquid chromatography–tandem mass spectrometry (DI/LC-MS/MS), proton nuclear magnetic resonance (¹H-NMR) spectroscopy, and inductively coupled plasma mass spectrometry (ICP-MS). Ketosis was confirmed by serum β-hydroxybutyrate concentrations ≥ 1400 μmol/L. Principal component analysis, partial least squares-discriminant analysis, and receiver operating characteristic (ROC) curve analyses were applied. All three platforms discriminated ketotic cows from healthy cows, with clear cluster separation validated by 2000 permutation tests (p < 0.05). DI/LC-MS/MS identified 16 significantly altered metabolites (p < 0.05), with butyrylcarnitine (C4), phosphatidylcholine 30:0 (PC 30:0), ether-linked phosphatidylcholine O-38:3 (PC O-38:3), and citrulline identified as the top discriminatory biomarkers (AUC = 0.920; 95% CI: 0.85–0.98; sensitivity = 91.7%; specificity = 93.3%). ICP-MS revealed significantly reduced selenium (Se, p = 0.017), manganese (Mn, p = 0.045), and chromium (Cr, p = 0.037), as well as elevated cobalt (Co, p = 0.014) in ketotic milk (AUC = 0.870). ¹H-NMR detected no individually significant metabolites; however, multivariate analysis distinguished groups (AUC = 0.890), with succinate (numerical fold change: +5.77×; p = 0.059), methanol (−1.94×; not significant), and acetate (+2.88×; not significant) as top VIP contributors. The combined multi-platform biomarker panel (joint classification using top VIP features from all three platforms, without formal data fusion) achieved superior diagnostic performance (AUC = 0.970; 95% CI: 0.93–1.00; sensitivity = 95.0%; specificity = 96.7%). These findings identify coordinated perturbations in glycerophospholipid metabolism, acylcarnitine profiles, amino acid homeostasis, antioxidant mineral status, and energy metabolism during early ketosis, and suggest that milk metabolomics is a promising non-invasive approach for precision dairy health monitoring, pending validation in independent cohorts. We acknowledge the small ketotic group size (n = 6) as a limitation; therefore, these findings should be considered discovery cohort observations requiring prospective validation before clinical translation.

The dry period is a critical window of susceptibility to intramammary infection in dairy cows, yet the metabolic environment of the mammary gland during this phase remains largely uncharacterized. The objective of this study was to profile the metabolome of bovine dry secretion fluid from quarters with subclinical mastitis (SCM; SCC ≥ 200,000 cells/mL) and healthy quarters (H; SCC < 200,000 cells/mL) on day 2 (D2) and day 21 (D21) of the dry period (n = 10 per group quarters per group, drawn from a cohort of 41 enrolled Holstein dairy cows) using high-performance chemical isotope labeling liquid chromatography–mass spectrometry (CIL-LC–MS). A total of 474 metabolites were positively identified. At D2, 186 metabolites differed significantly between SCM and H quarters, with dipeptides dominating the upregulated metabolites, indicating active proteolysis in infected quarters. Norepinephrine was the most significantly depleted metabolite (FC = 0.27, p = 3.37 × 10⁻⁷), pointing to local catecholamine exhaustion. By D21, only 36 metabolites remained altered, representing an 80.6% attenuation of the SCM signature. Interestingly, temporal changes from D2 to D21 far exceeded disease-related differences, with 316 metabolites shifting in both SCM and healthy quarters, establishing mammary involution as the dominant metabolic event during the dry period. Principal component and PLS-DA analyses confirmed that time, not disease status, was the primary driver of metabolic variation. Pathway analysis revealed significant perturbations in amino acid metabolism, glyoxylate and dicarboxylate metabolism, and tryptophan metabolism. These findings provide the first comprehensive metabolomic map of bovine dry secretion, reveal that subclinical mastitis superimposes a proteolytic and neuroimmune disruption onto the involution process, and identify candidate biomarkers for early detection of intramammary infection during the dry period.

The transition from energy sufficiency to deficiency triggers complex metabolic and immune adaptations that have traditionally been viewed through a reductionist pathological lens. During early lactation, coordinated mobilization of adipose tissue, muscle protein, and bone minerals supports milk synthesis, with ketogenesis specifically arising from hepatic oxidation of non–esterified fatty acids. This review introduces the Keto–Inflammatory Network (KIN), a novel framework positioning ketonemia as an evolutionarily conserved adaptive response rather than inherent metabolic dysfunction. The KIN integrates β–hydroxybutyrate (BHB) signaling with immune modulation, epigenetic regulation, circadian rhythms, and microbiota interactions. Through mechanisms including NLRP3 inflammasome inhibition, HDAC–mediated epigenetic modifications, and HCAR2 receptor activation, ketone bodies orchestrate anti–inflammatory responses while maintaining metabolic flexibility. Building upon important precedent work recognizing beneficial roles of ketones in ruminant metabolism, this review synthesizes recent advances in immunometabolism and systems biology into an integrated framework. The KIN encompasses calcium–ketone integration through the Calci–Keto–Inflammatory Code (CKIC), temporal regulation via the Ketoinflammatory Clock, and trans–kingdom signaling through microbiota interactions. In dairy cattle, this perspective reframes periparturient ketonemia as existing on a continuum from adaptive to pathological, with biological meaning determined by integrated metabolic–inflammatory patterns rather than absolute ketone concentrations. The CKIC paradigm, while requiring prospective validation, suggests novel therapeutic approaches leveraging ketone signaling for inflammatory diseases, autoimmune conditions, and metabolic disorders while challenging traditional threshold–based ketosis management strategies. This systems–level understanding opens new avenues for precision interventions that work with, rather than against, evolved adaptive mechanisms refined through millions of years of mammalian evolution. By distinguishing ketonemia (measurable ketone elevation) from pathological ketosis (dysregulated ketone accumulation), and by integrating evidence from both ruminant and monogastric models, this review provides a comprehensive framework for next–generation metabolic medicine.

The transition from energy sufficiency to deficiency triggers complex metabolic and immune adaptations that have traditionally been viewed through a pathological perspective. This review introduces the Keto-Inflammatory Network (KIN), a novel framework positioning ketosis as an evolutionarily conserved adaptive response rather than metabolic dysfunction. The KIN integrates β-hydroxybutyrate (BHB) signaling with immune modulation, epigenetic regulation, circadian rhythms, and microbiota interactions. Through mechanisms including NLRP3 inflammasome inhibition, HDAC-mediated epigenetic modifications, and HCAR2 receptor activation, ketone bodies orchestrate anti-inflammatory responses while maintaining metabolic flexibility. The framework encompasses calcium-ketone integration through the Calci-Keto-Inflammatory Code (CKOC), temporal regulation via the Ketoinflammatory Clock, and trans-kingdom signaling through microbiota interactions. In dairy cattle, this perspective reframes periparturient ketosis as potentially adaptive, supporting lactogenesis and immune tolerance during reproductive transition. The CKOC paradigm suggests therapeutic applications leveraging ketone signaling for inflammatory diseases, autoimmune conditions, and metabolic disorders while challenging traditional ketosis management strategies. This systems-level understanding opens new avenues for precision interventions that work with, rather than against, ancient adaptive mechanisms refined through evolution.